K B Holten1. Show Affiliations » 1. University of Cincinnati College of Medicine, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, InhalationAdrenergic beta-Agonists/therapeutic useAdultAsthma/drug therapyAsthma/physiopathologyBronchodilator Agents/administration & dosageBronchodilator Agents/adverse effectsBronchodilator Agents/therapeutic useConfidence IntervalsForced Expiratory Volume/drug effectsHospitalizationHumansIpratropium/administration & dosageIpratropium/adverse effectsIpratropium/therapeutic useMeta-Analysis as TopicOdds RatioRandomized Controlled Trials as TopicRespiration/drug effectsStatus Asthmaticus/drug therapyStatus Asthmaticus/physiopathologyTreatment Outcome
Substances： See more » Adrenergic beta-AgonistsBronchodilator AgentsIpratropium
Year: 2000 PMID： 11153407 PMCID： PMC2144999
Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275